BOLD earnings date and last-quarter result: last quarter miss, P/E -1.01. Updated 2026-07-23.
Boundless Bio (BOLD) Research Hub
Boundless Bio (BOLD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.41 USD (+2.12%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.01, market cap 0.06B. This hub links to the full technical, earnings and options research available for BOLD.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.41 USD (+2.12%) |
| 52-week range | 1.4 USD – 3.04 USD |
| Trend regime | Range |
| 14-day RSI | 38.6 (Bearish) |
| Trailing P/E | -1.01 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
Available research for BOLD
Covered Call on BOLD: how it works, illustrative setup around the real 2.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BOLD: how it works, illustrative setup around the real 2.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BOLD: how it works, illustrative setup around the real 2.41 USD price, max profit/loss, breakeven and when to use it. Educational.
BOLD technical analysis: range, last 2.41 USD, RSI 38.6, 52w range 1.4 USD–3.04 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BOLD in?
Boundless Bio (BOLD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BOLD in an uptrend or downtrend?
As of 2026-10-26, BOLD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BOLD's trailing P/E ratio?
BOLD's trailing P/E is -1.01, with a market cap of 0.06B. See the earnings research page for full valuation detail.